Members |
acceptabilityId |
'stent' coaté dans une artère coronaire |
Acceptable (foundation metadata concept) |
'stent' présent dans l'uretère |
Acceptable (foundation metadata concept) |
'steward' dans un accident d'avion |
Acceptable (foundation metadata concept) |
'strapping' d'un pied bot |
Preferred (foundation metadata concept) |
'strapping' patellaire |
Preferred (foundation metadata concept) |
'stress test' articulaire négatif |
Preferred (foundation metadata concept) |
'stress test' articulaire positif |
Preferred (foundation metadata concept) |
'stress test' cervical négatif |
Preferred (foundation metadata concept) |
'stress test' cervical positif |
Preferred (foundation metadata concept) |
'stripping' |
Preferred (foundation metadata concept) |
'stripping' d'un os |
Preferred (foundation metadata concept) |
'stripping' d'une veine saphène variqueuse |
Preferred (foundation metadata concept) |
'stripping' d'une veine variqueuse collatérale |
Acceptable (foundation metadata concept) |
'stripping' d'une veine variqueuse de l'abdomen |
Acceptable (foundation metadata concept) |
'stripping' de l'enthèse calcanéenne d'un muscle intrinsèque du pied |
Preferred (foundation metadata concept) |
'stripping' de la grande veine saphène |
Preferred (foundation metadata concept) |
'stripping' de la petite veine saphène |
Preferred (foundation metadata concept) |
'stripping' de veines variqueuses du membre supérieur |
Acceptable (foundation metadata concept) |
'stripping' de veines variqueuses du thorax |
Acceptable (foundation metadata concept) |
'stripping' de veines variqueuses à l'intérieur du crâne |
Acceptable (foundation metadata concept) |
'stripping' et ligature de la grande veine saphène |
Preferred (foundation metadata concept) |
'stripping' et ligature veineuse de la jambe |
Preferred (foundation metadata concept) |
'stripping' et ligature veineuse du membre inférieur |
Preferred (foundation metadata concept) |
'stripping' veineux |
Preferred (foundation metadata concept) |
'stroke test' du genou |
Preferred (foundation metadata concept) |
'sugar soap' |
Preferred (foundation metadata concept) |
'talon cusp' |
Acceptable (foundation metadata concept) |
'tennis toe' |
Acceptable (foundation metadata concept) |
'turf toe' |
Acceptable (foundation metadata concept) |
'turnover' osseux normal |
Acceptable (foundation metadata concept) |
'undercutting' de tissu périanal |
Acceptable (foundation metadata concept) |
'unroofing' au niveau du méat acoustique externe |
Preferred (foundation metadata concept) |
'unroofing' d'un pseudokyste du pavillon de l'oreille |
Preferred (foundation metadata concept) |
'unroofing' du CAE (conduit auditif externe) |
Acceptable (foundation metadata concept) |
'wood mix' : bois de pin, d'épicéa, de bouleau et de teck |
Acceptable (foundation metadata concept) |
(s)- tricyclamol |
Preferred (foundation metadata concept) |
/année |
Preferred (foundation metadata concept) |
/jour |
Preferred (foundation metadata concept) |
/mois |
Preferred (foundation metadata concept) |
/seconde |
Preferred (foundation metadata concept) |
/semaine |
Preferred (foundation metadata concept) |
0 à 5 mitoses sur 10 champs à fort grossissement, score à 1 |
Acceptable (foundation metadata concept) |
0,5 |
Preferred (foundation metadata concept) |
0,5 mL de poudre en flacon du vaccin vivant contre la rubéole |
Preferred (foundation metadata concept) |
0/5 de la tête du fœtus au-dessus du bord pelvien |
Acceptable (foundation metadata concept) |
0/5 de la tête fœtale au-dessus du bord pelvien |
Preferred (foundation metadata concept) |
0215 x 028 |
Preferred (foundation metadata concept) |
1,1,1,2-tétrachloro 2,2-difluoroéthane |
Preferred (foundation metadata concept) |
1,1,1-trichloroéthane |
Preferred (foundation metadata concept) |
1,1,2,2-tétrachloro 1,2-difluoroéthane |
Preferred (foundation metadata concept) |
1,1-dichlorobutane |
Preferred (foundation metadata concept) |
1,2-benzisothiazol-3(2H)-one |
Preferred (foundation metadata concept) |
1,2-benzisothiazol-3-one |
Acceptable (foundation metadata concept) |
1,2-diaminoéthane |
Acceptable (foundation metadata concept) |
1,2-dichloroéthylène |
Preferred (foundation metadata concept) |
1,25-dihydroxy-vitamine D |
Acceptable (foundation metadata concept) |
1,3,5-tris(2-hydroxyéthyl)-hexahydrotriazine |
Preferred (foundation metadata concept) |
1,3-dichloro-2-propanol |
Preferred (foundation metadata concept) |
1,4-diaminobenzène |
Acceptable (foundation metadata concept) |
1-(4-nitrophényl)-3-(3-pyridylméthyl)urée |
Acceptable (foundation metadata concept) |
1-1-bis-(p-chlorophényl)-2-nitrobutane |
Preferred (foundation metadata concept) |
1-1-bis-(p-chlorophényl)-2-nitropropane |
Preferred (foundation metadata concept) |
1-1-dichloro-1-nitroéthane |
Preferred (foundation metadata concept) |
1-chloro-1-nitropropane |
Preferred (foundation metadata concept) |
1-chloro-1-nitroéthane |
Preferred (foundation metadata concept) |
1-chloro-2,3-époxypropane |
Acceptable (foundation metadata concept) |
1-phényl-3-pyrazolidinone |
Acceptable (foundation metadata concept) |
1/2 mouvement |
Preferred (foundation metadata concept) |
1/4 de mouvement |
Preferred (foundation metadata concept) |
10 accouchements ou plus |
Acceptable (foundation metadata concept) |
10 figures mitotiques ou plus sur 10 champs à fort grossissement |
Acceptable (foundation metadata concept) |
10 grossesses |
Acceptable (foundation metadata concept) |
10 grossesses précédentes |
Acceptable (foundation metadata concept) |
10 microgrammes de polysaccharides contre l'Haemophilus influenzae et 24 microgrammes d'anatoxine tétanique |
Preferred (foundation metadata concept) |
10 µg/0,5 ml du vaccin contre l'hépatite B recombinant |
Preferred (foundation metadata concept) |
10^2 |
Preferred (foundation metadata concept) |
10^3 |
Preferred (foundation metadata concept) |
10^4 |
Preferred (foundation metadata concept) |
10^5 |
Preferred (foundation metadata concept) |
10^6 |
Preferred (foundation metadata concept) |
10^7 |
Preferred (foundation metadata concept) |
10^e^ au 25^e^ centile |
Preferred (foundation metadata concept) |
10e étage |
Acceptable (foundation metadata concept) |
11-désoxy-17-hydroxycorticostérone anormale |
Preferred (foundation metadata concept) |
11-désoxycorticostérone |
Acceptable (foundation metadata concept) |
11-désoxycorticostérone anormale |
Preferred (foundation metadata concept) |
110Ag - argent 110 |
Acceptable (foundation metadata concept) |
110mAg - argent 110m |
Acceptable (foundation metadata concept) |
111Ag - argent 111 |
Acceptable (foundation metadata concept) |
111In - indium 111 |
Acceptable (foundation metadata concept) |
111mAg - argent 111m |
Acceptable (foundation metadata concept) |
112Ag - argent 112 |
Acceptable (foundation metadata concept) |
113Ag - argent 113 |
Acceptable (foundation metadata concept) |
117Lu - lutécium 117 |
Acceptable (foundation metadata concept) |
11e étage et étages supérieurs |
Acceptable (foundation metadata concept) |
12 heures |
Preferred (foundation metadata concept) |
120I - iode 120 |
Acceptable (foundation metadata concept) |
121I - iode 121 |
Acceptable (foundation metadata concept) |
122I - iode 122 |
Acceptable (foundation metadata concept) |
123i-iode |
Preferred (foundation metadata concept) |
123i-iode iobenguane |
Preferred (foundation metadata concept) |